# Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis

> **NCT00884377** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 56 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Sodium stibogluconate (Pentostam)
- **DEVICE:** ThermoMed

## Key facts

- **NCT ID:** NCT00884377
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-03
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884377, "Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00884377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*